Development of natural fiber-supported high-strength autologous fibrin glue from human plasma
Source abstract
Abstract
Commercially available fibrin glue is expensive and contains fibrin and thrombin from different sources. This limits the use of this glue for bonding regular wounds, increases the cost for cardiovascular surgeries and aggravates the risk of inflammatory and immune systemic allergic reactions. This study aims to develop a stronger and affordable fibrin glue synthesized from the patient’s own plasma within a few minutes. Fibrin glue was synthesized by combining calcium chloride with human plasma and a gel-like adhesive was prepared for direct application. Different properties and morphological features of the autologous glue along with the fiber-supported one were evaluated for different concentrations (5, 10 and 20% w/v) of calcium chloride. 10% calcium chloride was found as the optimum with clotting time varying from 8 to 25 min for frozen plasma and 3 min for freshly prepared plasma. The average adhesion strength was 46.2, 55.8 and 40.5 g/cm2 for 5, 10 and 20% calcium chloride, respectively. The adhesion strength increased up to 74.8 g/cm2 due to the addition of 1 mL of 0.5% cellulose that addresses the issue of weaker adhesion strength found in typical autologous glue. The average water content was the lowest for 10% calcium chloride and was reduced to 15.3% after cellulose addition. The proposed fibrin glue has high adhesion strength like the commercial ones and can be prepared in a few minutes. This affordable, enhanced fibrin glue has the potential to be used in a wide range of applications without the risk of possible inflammatory and allergic reactions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemostasis and retained surgical items · Surgical Sutures and Adhesives · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering, Bangladesh University of Engineering and Technology, Dhaka, Bangladesh;
Department of Cardiac Surgery, National Heart Foundation and Research Institute, Dhaka, Bangladesh
References (46)
Show source-provided references
1. Majno G · 1975
2. Forrest RD · J Royal Soc Med · 1982 · 19810.1177/014107688207500310 ↗
3. Quinn JV · 2005
4. 10.1111/j.1537-2995.2008.01703.x10.1111/j.1537-2995.2008.01703.x ↗
5. 10.1007/BF0316510410.1007/BF03165104 ↗
6. 10.1016/j.athoracsur.2009.02.09210.1016/j.athoracsur.2009.02.092 ↗
7. 10.1016/j.ucl.2009.02.00210.1016/j.ucl.2009.02.002 ↗
8. 10.1016/j.tgie.2005.12.00710.1016/j.tgie.2005.12.007 ↗
9. 10.1080/01694243.2012.69180910.1080/01694243.2012.691809 ↗
10. 10.1201/978142007342310.1201/9781420073423 ↗
11. 10.1155/2014/20394310.1155/2014/203943 ↗
12. 10.1517/14712598.2013.84819310.1517/14712598.2013.848193 ↗
13. 10.1016/B978-0-323-07445-2.00007-010.1016/B978-0-323-07445-2.00007-0 ↗
14. 10.1371/journal.pone.015153310.1371/journal.pone.0151533 ↗
15. Petrie EM · 2007
16. 10.2147/IJN.S12467110.2147/IJN.S124671 ↗
17. 10.1038/s41598-018-38318-410.1038/s41598-018-38318-4 ↗
18. 10.1016/j.jiec.2019.02.02810.1016/j.jiec.2019.02.028 ↗
19. 10.1097/00002480-200503000-0001810.1097/00002480-200503000-00018 ↗
20. 10.1016/B978-0-12-397164-7.00034-310.1016/B978-0-12-397164-7.00034-3 ↗
21. Lew WK · Biologics · 2008 · 2 · 593
22. 10.1002/mabi.20120033210.1002/mabi.201200332 ↗
23. 10.4103/jcls.jcls_33_1810.4103/jcls.jcls_33_18 ↗
24. 10.1016/j.jcms.2016.05.02210.1016/j.jcms.2016.05.022 ↗
25. Baugh RF, Lim LM, Johnston JS, et al. Autologous fibrin sealant and method for making same. United States patent 7,838,039B2. 2010 Jan 27.
26. 10.1016/S0049-3848(99)00234-010.1016/S0049-3848(99)00234-0 ↗
27. 10.1002/jbm.82023011010.1002/jbm.820230110 ↗
28. 10.1371/journal.pone.015789410.1371/journal.pone.0157894 ↗
29. 10.1007/s10570-013-0006-410.1007/s10570-013-0006-4 ↗
30. 10.3390/ma202035310.3390/ma2020353 ↗
31. 10.1007/s00580-006-0664-910.1007/s00580-006-0664-9 ↗
32. Hess JR · Blood Transfus · 2010 · 8 · s9
33. 10.1016/S0142-9612(98)00121-510.1016/S0142-9612(98)00121-5 ↗
34. Todd JC · 1979
35. 10.1016/0022-1759(92)90313-I10.1016/0022-1759(92)90313-I ↗
36. 10.1177/11769351050010011010.1177/117693510500100110 ↗
37. Traver MA · Rev Urol · 2006
38. 10.2176/nmc.oa.2014-020310.2176/nmc.oa.2014-0203 ↗
39. 10.1021/bm100779410.1021/bm1007794 ↗
40. Rey L · 2004 · 20044939
41. 10.1007/978-1-4757-9027-610.1007/978-1-4757-9027-6 ↗
42. 10.4103/0019-5049.14464710.4103/0019-5049.144647 ↗
43. Tredree R · Eur J Hosp Pharm · 2006 · 12 · 3
44. 10.1163/156856104232322010.1163/1568561042323220 ↗
45. Cavichiolo JB · Int Arch Otorhinolaryngol · 2013 · 62
46. Bahrololumi N · J Clin Exp Dent · 2017 · 9 · 78